Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 8.32848 | 95 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 8.30853 | 94 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 8.0093 | 93 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 7.741 | 92 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 8.23773 | 94 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 8.33862 | 95 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 8.65545 | 96 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 8.32169 | 95 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 8.16147 | 94 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 8.0396 | 94 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 8.39635 | 95 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 8.11165 | 94 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 8.14081 | 94 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 8.06003 | 94 |